Outlook Therapeutics Inc (OTLK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | -92 | 1,505 | 0 | 0 | 0 |
| Cost of Goods | 917 | 440 | N/A | N/A | N/A |
| Gross Profit | -1,008 | 1,066 | N/A | N/A | N/A |
| Operating Expenses | 17,223 | 17,254 | 12,392 | 21,607 | 22,878 |
| Operating Income | -17,315 | -15,749 | -12,392 | -21,607 | -22,878 |
| Interest Expense | 215 | 49 | 19 | 0 | 478 |
| Other Income | 2,683 | -4,354 | -33,944 | 38,985 | 29,046 |
| Pre-tax Income | -14,847 | -20,153 | -46,354 | 17,378 | 5,691 |
| Income Tax | -1,555 | N/A | 3 | N/A | N/A |
| Net Income Continuous | -13,293 | -20,153 | -46,357 | 17,378 | 5,691 |
| Net Income | $-13,293 | $-20,153 | $-46,357 | $17,378 | $5,691 |
| EPS Basic Total Ops | -0.46 | -0.55 | -1.50 | 0.72 | 2.90 |
| EPS Basic Continuous Ops | -0.46 | -0.55 | -1.50 | 0.72 | 2.89 |
| EPS Diluted Total Ops | -0.46 | -0.55 | -1.50 | 0.72 | 5.70 |
| EPS Diluted Continuous Ops | -0.46 | -0.55 | -1.50 | 0.72 | 3.06 |
| EPS Diluted Before Non-Recurring Items | -0.22 | -0.44 | -0.40 | -0.89 | -0.77 |
| EBITDA(a) | $-17,285 | $-15,719 | $-12,362 | $-21,578 | $-22,849 |